Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DPP3 | Q9NY33 | 4/20 | 0.60 |
| ▸ | OPRM1 | P35372 | 3/20 | 0.59 |
| ▸ | TACR1 | P25103 | 1/20 | 0.59 |
| ▸ | CCKAR | P32238 | 2/20 | 0.58 |
| ▸ | CCKBR | P32239 | 2/20 | 0.58 |
| ▸ | F2 | P00734 | 1/20 | 0.57 |
| ▸ | GHSR | Q92847 | 3/20 | 0.57 |
| ▸ | NTSR2 | O95665 | 1/20 | 0.57 |
| ▸ | NTSR1 | P30989 | 1/20 | 0.57 |
| ▸ | SORT1 | Q99523 | 1/20 | 0.57 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.53 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.53 |
| ▸ | C5AR1 | P21730 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30867019 | 0.88 | CXCR4 (0.61) | OPRM1NTSR2NTSR1SORT1OPRK1 | |
| SCHEMBL30497472 | 0.88 | CXCR4 (0.55) | DPP3OPRM1TACR1CCKARCCKBR | |
| SCHEMBL31593261 | 0.86 | NTSR2 (0.51) | DPP3OPRM1TACR1CCKARCCKBR | |
| SCHEMBL31507728 | 0.86 | NTSR2 (0.68) | DPP3OPRM1TACR1NTSR2NTSR1 | |
| SCHEMBL31593306 | 0.86 | NTSR2 (0.55) | DPP3OPRM1TACR1GHSRNTSR2 | |
| SCHEMBL30921659 | 0.86 | NTSR2 (0.60) | DPP3OPRM1TACR1GHSRNTSR2 | |
| SCHEMBL29532761 | 0.86 | CCKBR (0.60) | OPRM1TACR1CCKARCCKBRGHSR | |
| SCHEMBL31593312 | 0.85 | NTSR2 (0.50) | DPP3OPRM1TACR1CCKARCCKBR | |
| SCHEMBL30007955 | 0.85 | NTSR2 (0.65) | DPP3OPRM1TACR1NTSR2NTSR1 | |
| SCHEMBL31516395 | 0.85 | CXCR4 (0.57) | DPP3CCKBRNTSR2NTSR1SORT1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250326791-A1 | Peptide-Based Drugs for I.N. Delivery to Brain | NATIONAL INSTITUTES OF HEALTH | 2025-10-23 | — | — | US | disclosed |
| US-12378285-B2 | Cyclic peptides and cyclic peptide conjugates for treating neurological disorders | FLORIDA ATLANTIC UNIVERSITY RESEARCH CORPORATION (US) | 2025-08-05 | — | — | US | disclosed |
| US-12187813-B2 | Methods of identifying opioid cyclic peptides | FLORIDA ATLANTIC UNIVERSITY BOARD OF TRUSTEES (US) | 2025-01-07 | — | — | US | disclosed |
| US-12129311-B2 | Cyclic peptide combinatorial libraries | FLORIDA ATLANTIC UNIVERSITY RESEARCH CORPORATION (US) | 2024-10-29 | — | — | US | disclosed |
| US-20240132543-A1 | CYCLIC PEPTIDE COMBINATORIAL LIBRARIES | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2024-04-25 | — | — | US | disclosed |
| US-20230295226-A1 | CYCLIC PEPTIDES AND CYCLIC PEPTIDE CONJUGATES FOR TREATING NEUROLOGICAL DISORDERS | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2023-09-21 | — | — | US | disclosed |
| US-20230257418-A1 | METHODS OF IDENTIFYING OPIOID CYCLIC PEPTIDES | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2023-08-17 | — | — | US | disclosed |
| US-11578100-B2 | Cyclic peptides, cyclic peptide conjugates and methods of use thereof | FLORIDA ATLANTIC UNIVERSITY RESEARCH CORPORATION (US) | 2023-02-14 | — | — | US | disclosed |